NCT06446830 The Analgesic Efficacy of Vitamin B Complex in Critically Ill Obstetrics After Caesarean Section
| NCT ID | NCT06446830 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Ain Shams University |
| Condition | Analgesia |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2024-05-25 |
| Primary Completion | 2025-11-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 100 participants in total. It began in 2024-05-25 with a primary completion date of 2025-11-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
We aim to investigate the value of vitamin B (B1, B6, B9, B12) on post-cesarean section analgesia in addition to the standard opioid-sparing multimodal regimen to achieve more robust analgesia with minimal side effects.
Eligibility Criteria
Inclusion Criteria: * Critically ill -obstetric patients who will be delivered by cesarean section under neuraxial anesthesia. Exclusion Criteria: 1. Patient's Refusal to participate 2. Known allergy to one or more of the given components. 3. Disturbed conscious level. 4. Prolonged or complicated surgery; defined by operative time of more than 90 min. 5. Severe liver dysfunction or failure 6. Severe renal dysfunction or failure. 7. Severe thrombocytopenia; platelets less than 50
Contact & Investigator
wessam selima, MD
PRINCIPAL INVESTIGATOR
assistant professor (lecturer)- Ain shams university
Frequently Asked Questions
Who can join the NCT06446830 clinical trial?
This trial is open to female participants only, studying Analgesia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06446830 currently recruiting?
Yes, NCT06446830 is actively recruiting participants. Contact the research team at w.z.selima@med.asu.edu.eg for enrollment information.
Where is the NCT06446830 trial being conducted?
This trial is being conducted at Cairo, Egypt.
Who is sponsoring the NCT06446830 clinical trial?
NCT06446830 is sponsored by Ain Shams University. The principal investigator is wessam selima, MD at assistant professor (lecturer)- Ain shams university. The trial plans to enroll 100 participants.